Antithrombotic Therapy and Direct Medical Costs in Patients with Acute Coronary Syndrome in Shanghai, China
Value Health
.
2014 Nov;17(7):A760.
doi: 10.1016/j.jval.2014.08.253.
Epub 2014 Oct 26.
Authors
J J Guo
1
,
L Liu
2
,
W Du
3
,
H Peng
4
,
R Wang
4
,
P Xin
5
,
Y Chen
6
,
P R Wigle
1
,
M Papadimitropoulos
7
Affiliations
1
University of Cincinnati, Cincinnati, OH, USA.
2
Eli Lilly Suzhou Pharmaceutical Co. Ltd., Shanghai, China.
3
Shanghai Food & Drug Administration, Shanghai, China.
4
University of Cincinnati College of Medicine, Cincinnati, OH, USA.
5
Eli-Lilly Company, Shanghai, China.
6
Eli Lilly Suzhou Pharmaceutical Co., Ltd., Shanghai, China.
7
Eli Lilly Canada, Toronto, ON, Canada.
PMID:
27202780
DOI:
10.1016/j.jval.2014.08.253
No abstract available